Japan· JP-2129409G1036
リドカイン塩酸塩
A lidocaine product containing リドカイン塩酸塩, registered in Japan by テルモ, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Lidocaine is registered in 8 of 19 countries.
Countries holding a registration under ATC C01BB01 (lidocaine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 5 of them publish a price we can compare per daily dose
Lidocaine · ATC C01BB01
8 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- リドカイン塩酸塩
- Manufacturer
- テルモ
- Country
- Japan (JP)
- ATC code
- C01BB01
- ATC class
- Lidocaine
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
640 interactions on record for lidocaine.
Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lidocaine · interactions on record
640 records
- 13 severe
- 171 moderate
- 82 minor
- 373 info
Most severe, free to view
- DofetilideC01BD04severe
- ArbutamineC01CA22severe
- ConivaptanC03XA02severe
- SaquinavirJ05AE01severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01BB01
Lidocaine, as other registers publish it.
- Canada0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTIONBAXTER CORPORATION
- FinlandLidocain 0,2% C Glucos 5%Orion Corporation Orion Pharma
- FinlandLidocain 0,4% C Glukos 5%Orion Corporation Orion Pharma
- FinlandLidocain Cum GlucosSchering Oy
- FinlandLidocain Cum GlucosSchering Oy
- NorwayLidocaine hydrochlorideFresenius Kabi Norge AS
- CanadaLIDOCAINE HYDROCHLORIDE INJECTIONLABORATOIRE AGUETTANT
- CanadaLIDOCAINE HYDROCHLORIDE INJECTION USPPFIZER CANADA ULC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd0c8dbb-f459-4a47-926d-9db127210fd8 GET /v1/drugs/dd0c8dbb-f459-4a47-926d-9db127210fd8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２％５ｍＬ１筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2129409G1036",
"category": "注射薬",
"price_yen": 176,
"generic_name": "リドカイン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2129",
"transitional_expiry": null
}See everything about lidocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.